Charles River and Distributed Bio enter exclusive partnership
Meet the Antibody Discovery Team | Charles River
Charles River Laboratories - Drug Target Review
Charles River teams with Distributed Bio to advance antibody discovery platform
Sarah Ives on Instagram: “We sold the company!! Distributed Bio is now owned by Charles River Labs. We are excited to join this fantastic organization, which works…”
Jacob Glanville, PhD, Joel Christian Andrade, PSM, and Ben Osborn - The Antibody Society
Charles River Labs Acquires Antibody Partner Distributed Bio for Up to $104M
Charles River Acquired Distributed Bio – Here's What it Means for the AI Ecosystem - Emersion Insights
Charles River Laboratories: Medium-Term Outlook Strong, But Overvalued (NYSE:CRL) | Seeking Alpha
Deal sees Charles River Labs acquire large-molecule discovery platform
Phage Antibody Discovery and Antibody Engineering | Charles River
Charles River Laboratories spends $83M to snap up Distributed Bio to boost antibody work | Fierce Biotech
Charles River teams with Distributed Bio to advance antibody discovery platform
Ted Buckman, CPA - Controller - Charles River Laboratories | LinkedIn
SuperHuman Antibody Library for Discovery | Charles River
Charles River teams with Distributed Bio to advance antibody discovery platform
Distributed Bio Partners With Charles River Laboratories – BroadOak Capital Partners
Deal sees Charles River Labs acquire large-molecule discovery platform
Charles River Labs on Twitter: "We are pleased to announce the full integration of Cognate BioServices, Cobra Biologics, Vigene Biosciences, Hemacare, Cellero, Distributed Bio, Retrogenix into Charles River. Learn about our end-to-end
Distributed Bio Company Profile: Acquisition & Investors | PitchBook
Charles River Labs Acquires Antibody Partner Distributed Bio for Up to $104M
A New Way to Target GPCRs | Charles River
Charles River Laboratories Acquires Distributed Bio | Business Wire
Charles River Labs buys South San Francisco's Distributed Bio Inc. in all-cash deal - Boston Business Journal
citybizlist : Boston : Charles River Laboratories to Acquire Cognate BioServices for $875 Million
